This is a Validated Antibody Database (VAD) review about human ING4, based on 3 published articles (read how Labome selects the articles), using ING4 antibody in all methods. It is aimed to help Labome visitors find the most suited ING4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ING4 synonym: my036; p29ING4; inhibitor of growth protein 4; brain my036 protein; candidate tumor suppressor p33 ING1 homolog

Proteintech Group
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 3
Proteintech Group ING4 antibody (Proteintech Group, 16188-1-AP) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 3). Mol Med Rep (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 6
In order to investigate the function of ING4 in normal, non-transformed primary fibroblasts, Proteintech Group ING4 antibody (Proteintech, 16188-1-AP) was used in western blot on human samples (fig 6). Oncogene (2014) ncbi
Invitrogen
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100
  • western blot; human; 1:1000
In order to examine the effects of ING4 expression in human bladder cancer, Invitrogen ING4 antibody (Invitrogen, 407700) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in western blot on human samples at 1:1000. Urol Int (2015) ncbi
Articles Reviewed
  1. Ren X, Liu H, Zhang M, Wang M, Ma S. Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo. Mol Med Rep. 2016;14:2431-8 pubmed publisher
  2. Wang Y, Wang T, Han Y, Wu H, Zhao W, Tong D, et al. Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder. Urol Int. 2015;94:464-71 pubmed publisher
  3. Moreno A, Soleto I, García Sanz P, Moreno Bueno G, Palmero I. ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth. Oncogene. 2014;33:1945-53 pubmed publisher